PMV Pharmaceuticals Inc.

NASDAQ: PMVP · Real-Time Price · USD
0.93
0.01 (1.16%)
At close: Jun 04, 2025, 3:59 PM
0.92
-0.61%
After-hours: Jun 04, 2025, 04:17 PM EDT

PMV Pharmaceuticals Statistics

Share Statistics

PMV Pharmaceuticals has 51.95M shares outstanding. The number of shares has increased by 0.95% in one year.

Shares Outstanding 51.95M
Shares Change (YoY) 0.95%
Shares Change (QoQ) 0.36%
Owned by Institutions (%) 75.54%
Shares Floating n/a
Failed to Deliver (FTD) Shares 11
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 840.93K, so 1.62% of the outstanding shares have been sold short.

Short Interest 840.93K
Short % of Shares Out 1.62%
Short % of Float 1.92%
Short Ratio (days to cover) 3.47

Valuation Ratios

The PE ratio is -1.33 and the forward PE ratio is -0.49. PMV Pharmaceuticals's PEG ratio is 0.06.

PE Ratio -1.33
Forward PE -0.49
PS Ratio 0
Forward PS 0.5
PB Ratio 0.44
P/FCF Ratio -1.5
PEG Ratio 0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for PMV Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.22, with a Debt / Equity ratio of 0.01.

Current Ratio 12.22
Quick Ratio 12.22
Debt / Equity 0.01
Debt / EBITDA -0.02
Debt / FCF -0.02
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-1,249,127.66
Employee Count 47
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -16.1M
Effective Tax Rate 21.52%

Stock Price Statistics

The stock price has increased by -47.37% in the last 52 weeks. The beta is 1.5, so PMV Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.5
52-Week Price Change -47.37%
50-Day Moving Average 0.97
200-Day Moving Average 1.37
Relative Strength Index (RSI) 49.13
Average Volume (20 Days) 181,971

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -85.45M
Net Income -58.71M
EBITDA -73.67M
EBIT -74.81M
Earnings Per Share (EPS) -1.14
Full Income Statement

Balance Sheet

The company has 40.88M in cash and 1.19M in debt, giving a net cash position of 39.69M.

Cash & Cash Equivalents 40.88M
Total Debt 1.19M
Net Cash 39.69M
Retained Earnings -368.71M
Total Assets 170.61M
Working Capital 153.74M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -51.28M and capital expenditures -655K, giving a free cash flow of -51.94M.

Operating Cash Flow -51.28M
Capital Expenditures -655K
Free Cash Flow -51.94M
FCF Per Share -1.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PMVP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for PMVP is $5, which is 455.6% higher than the current price. The consensus rating is "Buy".

Price Target $5
Price Target Difference 455.6%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score -1.15
Piotroski F-Score 1